NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reddit, Inc. ("Reddit, Inc.") (NYSE:RDDT) concerning possible violations of federal securities laws. On May 21, 2024, before market open, Baird lowered its price target for Reddit to $120 from $140, citing concerns about artificial intelligence (AI) capabilities being utilized by tech powerhouses like Alphabet.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=151246&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=151244&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151242&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=151247&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=151248&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151243&wire=1&utm_campaign=24 or contact Joseph E.

TKO Group's unique WWE-UFC merger creates a live-sports powerhouse with strong revenue growth, margin expansion, and visible catalysts for further upside. The Netflix deal rebundles WWE for a global audience, locking in high-margin, inflation-linked licensing fees and de-risking revenue from advertising volatility. UFC's upcoming rights renewal could double current economics, while new assets and cost synergies support durable double-digit EBITDA growth and capital returns.

PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) (NYSE: BBAI) on behalf of purchasers of BigBear securities between March 31, 2022 through March 25, 2025, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired BigBear securities during the Class Period may, no later than JUNE 10, 2025 , seek to be appointed as a lead plaintiff representative of the class.

The Campbell's Company (CPB) on Monday reported fiscal third-quarter results that topped estimates, but warned that its full-year profit would likely come in at the low end of its previous forecast.

PBR signs a EUR 250 million deal with Mota-Engil to deliver advanced offshore construction and maintenance services across key platforms in Brazil's pre-salt Santos Basin.

Regeneron Pharmaceuticals (NASDAQ:REGN) shares witnessed a notable 19% decline on Friday, May 30, in the wake of the unexpected failure of itepekimab, its chronic obstructive pulmonary disease (COPD) treatment in conjunction with Sanofi, during a late-stage clinical trial. One of the two trials did not achieve its primary endpoint, which is a significant setback considering that itepekimab was anticipated to become a blockbuster drug, with peak sales projections from Sanofi estimated between $2 billion and $6 billion.

Summit Therapeutics (NASDAQ: SMMT) experienced a significant 30% decrease in its stock on Friday, May 30th, closing at $18. This sudden decline came even though the stock had doubled within the past year, driven by favorable updates regarding its lung cancer medication, ivonescimab.

SAN DIEGO , June 2, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Compass Diversified Holdings (NYSE: CODI) publicly traded securities between May 1, 2024 and May 7, 2025, inclusive (the "Class Period"), have until Tuesday, July 8, 2025 to seek appointment as lead plaintiff of the Compass Diversified class action lawsuit. Captioned Augenbaum v.

COSTA MESA, Calif. and VANCOUVER, BC , June 2, 2025 /PRNewswire/ -- Brookfield Residential, a leading land developer and homebuilder in North America, is pleased to announce the launch of a strategic joint venture with Trez Capital, a leader in North American commercial real estate investments, to develop a new master-planned community in Central Florida named Osprey Creek.

LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Zenas BioPharma, Inc. ("Zenas" or "the Company") (NASDAQ: ZBIO) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted on September 13, 2024, are encouraged to contact the firm before June 16, 2025.

ATHENS, Greece, June 02, 2025 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned subsidiary, it has entered into a time charter contract with Bohai Ocean Shipping (Singapore) Holding Pte. Ltd., for one of its Newcastlemax dry bulk vessels, the m/v Newport News. The gross charter rate is US$25,000 per day, minus a 5.00% commission paid to third parties, for a period until minimum September 1, 2026 up to maximum October 31, 2026. The charter is expected …

PHILADELPHIA , June 2, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) on behalf of purchasers of Viatris securities between August 8, 2024 through February 26, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired Viatris securities during the Class Period may, no later than JUNE 3, 2025 , seek to be appointed as a lead plaintiff representative of the class.

PBA offers robust earnings, dividend growth and strategic contracts but faces commodity volatility, regulatory risks and project delays.

AREC expands refining deal with ReElement, targeting more than $29 million in annual revenues from U.S. defense and commercial markets.